Neoplasms, Colorectal Terminated Phase 1 Trials for Labetuzumab (DB05097)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00041691Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After SurgeryTreatment